×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
HemoSonics' Quantra® Hemostasis System
Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot
Dr. Jonathan Sadeh, ex-SVP of Immunology R&D at Bristol-Myers Squibb, joins Scinai Immunotherapeutics' Scientific Advisory Board
BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog®
Vaxxas begins a Phase I clinical trial for an H7N9 influenza vaccine using its high-density microarray patch (HD-MAP)
Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time
UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.
nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.
Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research
FDA approves Bristol Myers Squibb's COBENFY™, a novel treatment for adult schizophrenia.
Featured Press Releases
MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
15 Aug 2024
XiFin, Inc., a leading provider of innovative healthcare information technologies and services
...
Biotheryx Announces First Patient Dosed in Phase 1 Clinical Trial of BTX-9341
Vensica Medical raises $11M to advance Phase 2 trials for its overactive bladder treatment
Kiromic BioPharma reports positive results from third patient in Deltacel-01 trial
Merz Aesthetics launches Ultherapy PRIME, the next generation of nonsurgical skin lifting treatments
Isotopia collaborates with LIVEKIDNEY.BIO, marking a breakthrough in lupus treatment advancements
By
Isotopia
Isotopia
12 Dec 2024
ADC Therapeutics shares promising initial LOTIS-7 trial data on ZYNLONTA® combined with a bispecific antibody for relapsed/refractory DLBCL.
By
ADC Therapeutics SA
ADC Therapeutics SA
11 Dec 2024
MM+M honors Petauri's Nicole Lodowski as a 2025 40 Under 40 awardee
By
Petauri
Petauri
11 Dec 2024
Pilatus Biosciences Inc. earns FDA Orphan Drug Designation for PLT012, targeting liver and intrahepatic bile duct cancer
By
Pilatus Biosciences
Pilatus Biosciences
10 Dec 2024
Biolexis Therapeutics reports positive outcomes for BLX-7006 in an expanded Diet-Induced Obesity (DIO) model study
By
Biolexis Therapeutics Inc
Biolexis Therapeutics Inc
09 Dec 2024
UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors
By
UroMems
UroMems
06 Dec 2024
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Kiromic BioPharma reports positive results from third patient in Deltacel-01 trial
By
Kiromic BioPharma, Inc
Apr 02
Orthofix Receives FDA 510(k) Clearance for Rodeo™ Telescopic Nail
By
Orthofix Medical Inc.
May 09
Onconic Therapeutics gets MFDS nod for JAQBO, a fresh remedy for Gastroesophageal Reflux Disease
By
onconic Therapeutics
Apr 25
December
2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe for e-Newsletter Monthly
Subscribe to the Pharmaceutical Era newsletter to receive timely updates from your favorite products.
Email
I consent to subscribing to the selected email lists.
Enter the code below
Subscribe
1
